Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|October 23, 2004
Detection of epithelial ovarian cancer using 1H-NMR-based metabonomicsKunle Odunsi, Robert M Wollman, Christine B Ambrosone, et al.
Gynecologic Oncology|October 13, 2015
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group studyLisa M Hess, Helen Q Huang, Alexandra L Hanlon, et al.
Oncotarget|July 18, 2020
Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancerTakemasa Tsuji, Kevin H Eng, Junko Matsuzaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2012
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patientsKunle Odunsi, Junko Matsuzaki, Julia Karbach, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 25, 2019
Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG StudyGustavo C Rodriguez, James Kauderer, Jessica Hunn, et al.
Cancer Immunology Research|February 19, 2014
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancerKunle Odunsi, Junko Matsuzaki, Smitha R James, et al.
Gynecologic Oncology|November 21, 2022
Carboplatin enhances lymphocyte-endothelial interactions to promote CD8+ T cell trafficking into the ovarian tumor microenvironmentJaron Mark, Dan T Fisher, Minhyung Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancerPaul Sabbatini, Jakob Dupont, Carol Aghajanian, et al.
Cancer Research|October 3, 2003
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancerKunle Odunsi, Achim A Jungbluth, Elisabeth Stockert, et al.
Cancer Research|June 4, 2009
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancerFeng Qian, Jeannine Villella, Paul K Wallace, et al.
Pageof 11